Eastern Health Newfoundland & Labrador Centre for Molecular Imaging and Research

Similar documents
Physical Bases : Which Isotopes?

Medical Use of Radioisotopes

Isotopes in Functional Cancer Imaging

Practice and Risk at Medical Facilities in Agency Operations

Guideline & Reports 医学物理学会教育委員会資料

+ Paper presented at the 14th International Conference on

Appendix A: Introduction to Imaging Modalities for Which Data Were Collected in the 2017 Imaging Inventory

CYCLOTRONS WORLD MARKET REPORT & DIRECTORY EDITION TOC and Summary USED IN NUCLEAR MEDICINE MARKET DATA, COMPANIES PROFILES.

Twelfth Annual Warren K. Sinclair Keynote Address

Establishing and Expanding Nuclear Medicine Programes

Radiopharmacy. Prof. Dr. Çetin ÖNSEL. CTF Nükleer Tıp Anabilim Dalı

RADIATION MONITORING EXPERIMENT USING THERMOLUMINESCENT DOSIMETER FOR THE TR 19 CYCLOTRON AREA IN NUCLEAR RESEARCH INSTITUTE

PHYS 383: Applications of physics in medicine (offered at the University of Waterloo from Jan 2015)

Quantitative Theranostics in Nuclear Medicine

Radionuclides in Medical Imaging. Danielle Wilson

Option D: Medicinal Chemistry

ADVANCES IN RADIATION TECHNOLOGIES IN THE TREATMENT OF CANCER

45 Hr PET Registry Review Course

Radiation physics and radiation protection. University of Szeged Department of Nuclear Medicine

Market Survey. Technical Description Irradiation Tests

Radiotherapy. Marta Anguiano Millán. Departamento de Física Atómica, Molecular y Nuclear Facultad de Ciencias. Universidad de Granada

The SCK-CEN Activities in Neutron Dosimetry

Itroduction to the Nuclear Medicine: biophysics and basic principles. Zámbó Katalin Department of Nuclear Medicine

EORTC Member Facility Questionnaire

CT Quality Control Manual FAQs

Radionuclide & Radiopharmaceuticals

Overview of Radiation Monitoring Laboratory Capabilities in Tunisia. Azza Hammou, CNRP, Tunis RMCC-8 Meeting, Amman Jordan JUNE 2013 CONTENT

Radiation Assurance Research Exposure Form

Description of the consecutive stages (which took place from December 2002 to July 2003)

This article is downloaded from. It is the paper published as: Author: G. M. Currie, H. Kiat and J. M.

New Radiation Health Technologies Challenges, Opportunities, Limitations

Applications of Particle Accelerators

Characterization and implementation of Pencil Beam Scanning proton therapy techniques: from spot scanning to continuous scanning

Peak temperature ratio of TLD glow curves to investigate the spatial variation of LET in a clinical proton beam

REPORT OF THE TECHNICAL MEETING: THE NEW DOSE LIMIT FOR THE LENS OF THE EYE IMPLICATIONS AND IMPLEMENTATION VIENNA, 2-4 OCTOBER 2012

Martin Law, PhD, DABSNM, DABMP Physicist ic Radiology/QMH

Process Control Methods in Radiation Technologies

Beyond FDG: International Symposium on PET Tracers in Oncology

Department of Nuclear Medicine with Positron Emission Tomography

A. DeWerd. Michael Kissick. Larry. Editors. The Phantoms of Medical. and Health Physics. Devices for Research and Development.

Calibration of Radiation Instruments Used in Radiation Protection and Radiotherapy in Malaysia

Mobile PET Center Project

Special Considerations for Tracers Based on Proteins or Protein Fragments

X-ray Safety Discussion and Tour for Health Physicists

Strategy for Sustainable Utilization of IRT-Sofia Research Reactor

OPPORTUNITIES IN BRACHYTHERAPY

Nuclear Medicine and PET. D. J. McMahon rev cewood

Targeted Alpha Particle Therapy: Imaging, Dosimetry and Radiation Protection

OTHER NON-CARDIAC USES OF Tc-99m CARDIAC AGENTS Tc-99m Sestamibi for parathyroid imaging, breast tumor imaging, and imaging of other malignant tumors.

Large-area Two-Dimensional Thermoluminescence Dosimetry System in Ion Beam Quality Assurance

COMPARISON OF RADIOBIOLOGICAL EFFECTS OF CARBON IONS TO PROTONS ON A RESISTANT HUMAN MELANOMA CELL LINE

Radiation Exposure to Staff Using PET/CT Facility

Feasibility study to develop BNCT facility at the Indonesian research reactor

PRINCIPLES and PRACTICE of RADIATION ONCOLOGY. Matthew B. Podgorsak, PhD, FAAPM Department of Radiation Oncology

Nuclear Radiation Today

NUCLEAR PHYSICS FOR MEDICINE - HADRON THERAPY. Pawel Olko Institute of Nuclear Physics Krakow Poland

Nuclear energy, nuclear technologies, and radiological protection Vocabulary. Part 4: Dosimetry for radiation processing

Plans for the Precision Cancer Medicine Institute University of Oxford

Neutron-Gamma Mixed field Dosimetry on a Child phantom under Therapeutic Proton Irradiation using TL Dosimeters

Imaging Rotation. University of Michigan Department of Radiation Oncology Division of Radiation Physics. Resident:

Workshop on Hadron Beam Therapy of Cancer Erice, Sicily April 24-May

Radiohalogen Molecular Imaging and Therapy Agents at MDS Nordion

Radiation Protection Program Update: The Details. July 2010

Steven G. Marsh MS, DABMP, Medical Health Physics RSO - Baystate Health Springfield, MA

Austin Radiological Association Ga-68 NETSPOT (Ga-68 dotatate)

International Conference on Clinical PET and Molecular Nuclear Medicine (IPET 2011)

SUMITOMO Particle Therapy Technologies

Proton Treatment. Keith Brown, Ph.D., CHP. Associate Director, Radiation Safety University of Pennsylvania

Simulating Potential Layouts for a Proton Therapy Treatment Center

NEUTRON THERAPY PLANNING

IEC Subcommittee 62C (Equipment for Radiotherapy, Nuclear Medicine and Radiation Dosimetry): Recent and Active Projects

Monte Carlo Modelling: a reliable and efficient tool in radiation dosimetry

Neutrons. ρ σ. where. Neutrons act like photons in the sense that they are attenuated as. Unlike photons, neutrons interact via the strong interaction

Atoms for Health. Atoms for Health The. Atoms for Health - Division of Nuclear Health - Dept of Nuclear Aplications P Andreo DIR-NAHU 1

TENTH NEUTRON USERS CLUB TECHNOLOGY TRANSFER ACTIVITIES OF THE NATIONAL MEASUREMENT SYSTEM PROGRAMME FOR IONISING RADIATION METROLOGY.

H. Röcken, M. Abdel-Bary, E. Akcöltekin, P. Budz, T. Stephani, J. Wittschen

AAPM Task Group 108: PET and PET/CT Shielding Requirements

Technical Meeting on Quality Assurance and Quality Control Activities in Nuclear Power Plants: Lessons Learned and Good Practices

Measures taken by the authority. to reduce extremity doses. in nuclear medicine facilities. in Switzerland

IAEA Activities related to Nuclear Medicine

RELIANT HOLDINGS LTD AND ITS AFFILIATES Safety Management System. Preparation: Safety Mgr Authority: CEO Issuing Dept: Safety Page: Page 1 of 5

Design of a BSA for Producing Epithermal Neutron for BNCT

Theragnostics for bone metastases. Glenn Flux Royal Marsden Hospital & Institute of Cancer Research Sutton UK

Introduction to REM-NM Radiation Exposure Monitoring for Nuclear Medicine. Jeff Pohlhammer, Charles Smith

PERSONNEL MONITORING AND DOSIMETRY POLICIES

Typical PET Image. Elevated uptake of FDG (related to metabolism) Lung cancer example: But where exactly is it located?

General Nuclear Medicine

Report to the 18 th Meeting of the CCRI(I), May 2007 Recent Activities in Measurement Standards and Dosimetry at METAS,

BORDET DEPARTMENT RADIATION ONCOLOGY

Production and Use of the Radiopharmaceuticals ( 18 F-FDG and 18 F-NaF) in Nuclear Medicine in Kazakhstan

Cardiac Nuclear Medicine

Application of the Commission's Recommendations for the Protection of People in

ISO INTERNATIONAL STANDARD

ICRP 128 ICRP ICRP ICRP 1928

Proiect IMAGO-MOL: Dezvoltarea imagisticii funcţionale în regiunea Nord-Est. Walther Bild, MD, PhD

CIRMS: A Retrospective & Look Forward

III. Proton-therapytherapy. Rome SB - 5/5 1

Basic radiation protection & radiobiology

Therapeutic Medical Physics. Stephen J. Amadon Jr., Ph.D., DABR

RADIOTRACERS FOR MYOCARDIAL PERFUSION IMAGING

Transcription:

Eastern Health Newfoundland & Labrador Centre for Molecular Imaging and Research Date form last updated: 2016 May 30 Completed by: Julio Panama, Cyclotron Engineer 1. Cyclotron Facility Contact info Institute (name/address): Institution URL: Person in charge (name/ph#/email): Position/title: Cyclotron manager/engineer (name/ph#/email) QA manager (name/ph#/email) QC manager Other senior staff (titles/name/ph#/email): Eastern Health Newfoundland & Labrador Centre for Molecular Imaging and Research 300 Prince Phillip Drive, St. John s, NL A1B3V6 www.easternhealth.ca Manager Cyclotron/Pharmacy/QA Julio Panama julio.panama@easternhealth.ca TBD TBD Dr. Bassem Elshahat bassemelshahat@hotmail.com Dr. Edward Kendall Edward.kendall@mun.ca Dr. Jeffery Flemming Jeffery.flemming@easternhealth.ca 2. Cyclotron characteristics Cyclotron manufacturer/model IBA Cyclone HC 18/18 Cyclotron installation date (Year): 2016 Dual beam? No Yes Any upgrades?, Describe: Particles: 1 H 2 H 3 He 4 He Particle energy, or range (MeV): 18 1 H 2 H 3 He 4 He Max particle current (ua): _150 1 H 2 H 3 He 4 He Typical particle current (ua): 1 H 2 H 3 He 4 He 3. Cyclotron Operation Prefer not to answer Planned operating days per week: 1 2 3 4 5 6 7 Number of planned maintenance days/month: TBD Number of planned shutdown weeks per year: TBD Total operating hours (h)/week: TBD h/week for radionuclide production: h/week for research: h/week for maintenance: h/week for applications:

4. Is the cyclotron used to produce Prefer not to answer Calibration sources? (specify which & quantity) Mossbauer sources? (specify which & quantity) X-ray sources? (specify which & quantity) Intense neutron beam? (specify average E n =?) 5. Application questions Prefer not to answer Are pre-clinical studies using cyclotron radiopharmaceuticals carried out on-site? Are clinical studies using cyclotron radiopharmaceuticals carried out on-site? Are cyclotron radionuclides/labelled compounds used or planned to be used for agricultural applications such as plant biochemistry/research? Is the cyclotron used for nuclear reaction cross-section measurements? Is the cyclotron used for targetry development? Is the cyclotron used for materials science? Is the cyclotron used for radiography? Is the cyclotron used for radiobiology? Is the cyclotron used for physics research? Is the cyclotron used for activation analysis? Is the cyclotron used for proton therapy? Is the cyclotron used for neutron therapy? Other (specify) No Yes (if available, types of radiotracers and name(s) and email(s) of PIs): Dr. Edward Kendall edward.kendall@mun.ca Dr. Bassem Elshahat bassemelshahat@hotmail.com No Yes (if available, types of radiotracers and name(s) and email(s) of PIs): Dr. Jeffery Flemming Jeffery.flemming@easternhealth.ca No Yes (if available, types of radiotracers and name(s) and email(s) of PIs): No Yes (if available, types of isotopes, and name(s) and email(s) of PIs):

6. Types of imaging equipment N/A, Prefer not to answer Single photon (specify if gamma camera, SPECT, or SPECT-CT): Number of clinical scanners: 6 Number of pre-clinical scanners: 1 (anticipated 2017) Number of plant biochemistry scanners: PET (specify if PET, PET/CT, or PET/MR): Number of clinical scanners: 1 Number of pre-clinical scanners: 2 (anticipated 2017) Number of plant biochemistry scanners: 7. Do you supply radionuclide(s), radiotracer(s), or radiopharmaceutical(s) to other institutions? ( No/ Yes/ Prefer not to answer). If yes, and if available, please provide the name of product, institution, and supply frequency: Product Institution Frequency 8. Cyclotron/radionuclide/radiochemistry/radiopharmacy training Is the cyclotron used for education and training in nuclear sciences, health physics, etc? Does your institute participate in trainee exchange (for production): Does your institute participate in trainee exchange (for research): Does your institute accept IAEA research fellows for training/experience: Other training opportunities (specify): 9. Radionuclide production 18 F(F - ) N/A, Prefer not to answer Reaction 18 O(p,n) 18 F; 16 O( 3 He,p) 18 F; 20 Ne(d,γ) 18 F; 16 O(α,d) 18 F Typical current (µa): Typical energy (MeV): Typical target pressure (psi):

Is target He cooled? Typical beam time (min): Typical Y sat if known (GBq/µA) % Isotopic enrichment 18 O 18 O supplier(s) Target volume [ 18 O]H 2 O (ml) Usage per year [ 18 O]H 2 O (ml) Do you recycle [ 18 O]H 2 O? (if yes, in-house return to supplier) 10. Radionuclide production 11 C ([ 11 C]CH 4 ) N/A, Prefer not to answer Typical current (µa): Typical energy (MeV): Typical target pressure (psi): Typical beam time (min): Typical Y sat if known (GBq/µA): Gas mixture: Target volume: [ 11 C]CH 3 I production : Typical yield (%, d.c.): 11. Radionuclide production 11 C ([ 11 C]CO 2 ) N/A, Prefer not to answer Typical current (µa): Typical energy (MeV): Typical target pressure (psi): Typical beam time (min): Typical Y sat if known (GBq/µA): Gas mixture: Target volume: [ 11 C]CH 3 I production : Typical yield (%, d.c.): Product 12. Other radionuclides produced N/A, Prefer not to answer Yield on batch (GBq) Irradiation parameters (MeV/µA/min) Typical target mass/material Extraction method Used on site? Distribution/ sales? 13 N 15 O 18 F-F 2

44 Sc 64 Cu 67 Ga 86 Y 89 Zr 94m Tc 99m Tc 103 Pd 111 In 123 I 124 I 201 Tl 211 At Other: 13. Radiopharmaceutical production 18 F(FDG) N/A, Prefer not to answer Production frequency (batches/week) Used on site Distribution/sales N/A N/A 14. Radiopharmaceutical production Other Products (please copy table for as many products as desired) N/A, Prefer not to answer Product: Production frequency (batches/week) Stage: Used on site Distribution/sales R&D Pre-clinical Clinical

N/A 15. Radionuclides and radiopharmaceuticals planned to be produced in the next 1-3 years (specify) N/A, Prefer not to answer Product: F18 C11 N13 I123 I124 Ga68 Tc99m Application: 16. Additional comments: N/A